World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
75
Citations
29343
World Ranking
18991
National Ranking
9466

Research.com Recognitions

  • 1997 - ACM Fellow For research contributions to the areas of natural language processing and digital libraries as well as outstanding leadership in Computer Science.

Overview

Robert L. Wilensky is affiliated with the University of Pennsylvania in the United States. Their research primarily focuses on Medicine with a strong emphasis on Cardiology and Cardiovascular Medicine, Surgery, Hepatology, Economics and Econometrics, and Pulmonary and Respiratory Medicine.

The scientist's recent publications cover a range of topics within these fields. Notable works include:

  • "Prospective CYP2C19 Genotyping to Guide Antiplatelet Therapy Following Percutaneous Coronary Intervention" (2020) published in Circulation Genomic and Precision Medicine
  • "Management of spontaneous coronary artery dissection: Trends over time" (2023) published in Vascular Medicine
  • "Impact Of Cirrhosis On 90-Day Outcomes After Percutaneous Coronary Intervention (from A Nationwide Database)" (2020) published in The American Journal of Cardiology
  • "One-Year Outcomes of Percutaneous Coronary Intervention in Patients with End-Stage Liver Disease" (2020) published in Clinical Medicine Insights Cardiology
  • "Stent-based delivery of AAV2 vectors encoding oxidation-resistant apoA1" (2022) published in Scientific Reports

Research topics covered by the scientist include:

  • Cardiovascular Issues in Pregnancy
  • Cardiac Structural Anomalies and Repair
  • Liver Disease and Transplantation
  • Abdominal Vascular Conditions and Treatments
  • Coronary Interventions and Diagnostics
  • Antiplatelet Therapy and Cardiovascular Diseases
  • Lipoproteins and Cardiovascular Health

Frequent co-authors collaborating with the scientist are:

  • William Matthai
  • Jay Giri
  • Elizabeth Thompson
  • Jennifer Lewey
  • Daniel Y. Lu

The scientist has published articles in several journals, among them:

  • Circulation Genomic and Precision Medicine
  • Vascular Medicine
  • Clinical Medicine Insights Cardiology
  • The American Journal of Cardiology
  • Scientific Reports

Robert L. Wilensky was recognized as an ACM Fellow in 1997 for research contributions to the areas of natural language processing and digital libraries as well as outstanding leadership in Computer Science.

Best Publications

  • Variant of transcription factor 7-like 2 (TCF7L2) gene confers risk of type 2 diabetes.

    Struan F. A. Grant;Gudmar Thorleifsson;Inga Reynisdottir;Rafil Benediktsson

  • Cholesterol efflux capacity, high-density lipoprotein function, and atherosclerosis

    Amit V. Khera;Marina Cuchel;Margarita de la Llera-Moya;Amrith Rodrigues

  • A variant in CDKAL1 influences insulin response and risk of type 2 diabetes.

    Valgerdur Steinthorsdottir;Gudmar Thorleifsson;Inga Reynisdottir;Rafn Benediktsson

  • Genome-wide association of early-onset myocardial infarction with single nucleotide polymorphisms and copy number variants.

    Sekar Kathiresan;Benjamin F Voight;Shaun Purcell;Kiran Musunuru

  • Stent-Based Delivery of Sirolimus Reduces Neointimal Formation in a Porcine Coronary Model

    Takeshi Suzuki;Greg Kopia;Shin Ichiro Hayashi;Lynn R. Bailey

  • Two variants on chromosome 17 confer prostate cancer risk, and the one in TCF2 protects against type 2 diabetes

    Julius Gudmundsson;Patrick Sulem;Valgerdur Steinthorsdottir;Jon T. Bergthorsson

  • A quantitative, randomized study evaluating three methods of mesenchymal stem cell delivery following myocardial infarction.

    Toby Freyman;Glenn Polin;Hashim Osman;Jody Crary

  • Thrombolysis for Pulmonary Embolism and Risk of All-Cause Mortality, Major Bleeding, and Intracranial Hemorrhage: A Meta-analysis

    Saurav Chatterjee;Anasua Chakraborty;Ido Weinberg;Mitul Kadakia

  • Effect of renal denervation on blood pressure in the presence of antihypertensive drugs: 6-month efficacy and safety results from the SPYRAL HTN-ON MED proof-of-concept randomised trial

    David E Kandzari;Michael Böhm;Felix Mahfoud;Felix Mahfoud;Raymond R Townsend

  • Catheter-based renal denervation in patients with uncontrolled hypertension in the absence of antihypertensive medications (SPYRAL HTN-OFF MED): a randomised, sham-controlled, proof-of-concept trial

    Raymond R Townsend;Felix Mahfoud;Felix Mahfoud;David E Kandzari;Kazuomi Kario

  • Meta-analysis and imputation refines the association of 15q25 with smoking quantity

    Jason Z. Liu;Federica Tozzi;Dawn M. Waterworth;Sreekumar G. Pillai

  • Fenoldopam Mesylate for the Prevention of Contrast-Induced Nephropathy: A Randomized Controlled Trial

    Gregg W. Stone;Peter A. McCullough;James A. Tumlin;Norman E. Lepor

  • Refining the impact of TCF7L2 gene variants on type 2 diabetes and adaptive evolution

    Agnar Helgason;Snæbjörn Pálsson;Snæbjörn Pálsson;Gudmar Thorleifsson;Struan F A Grant;Struan F A Grant

  • Efficacy of catheter-based renal denervation in the absence of antihypertensive medications (SPYRAL HTN-OFF MED Pivotal): a multicentre, randomised, sham-controlled trial

    Michael Böhm;Kazuomi Kario;David E. Kandzari;Felix Mahfoud;Felix Mahfoud

  • Inactivating mutations in NPC1L1 and protection from coronary heart disease

    Nathan O. Stitziel;Hong Hee Won;Alanna C. Morrison;Gina M. Peloso

  • Genetic associations at 53 loci highlight cell types and biological pathways relevant for kidney function

    Cristian Pattaro;Alexander Teumer;Mathias Gorski;Audrey Y. Chu

  • Volume-to-creatinine clearance ratio : A pharmacokinetically based risk factor for prediction of early creatinine increase after percutaneous coronary intervention

    Warren K. Laskey;Charles Jenkins;Faith Selzer;Oscar C. Marroquin

  • Inhibition of lipoprotein-associated phospholipase A2 reduces complex coronary atherosclerotic plaque development

    Robert L Wilensky;Yi Shi;Emile R Mohler;Damir Hamamdzic

  • Fenoldopam Mesylate for the Prevention of Contrast-Induced Nephropathy

    Gregg W. Stone;Peter A. McCullough;James A. Tumlin;Norman E. Lepor

  • Cholesterol Efflux Capacity, High-Density Lipoprotein Function, and Atherosclerosis

    A.V. Khera;M. Cuchel;M. de la Llera-moya

Frequent Co-Authors

Emile R. Mohler
Emile R. Mohler University of Pennsylvania
Daniel J. Rader
Daniel J. Rader University of Pennsylvania
Alice K. Jacobs
Alice K. Jacobs Boston University
David O. Williams
David O. Williams Brigham and Women's Hospital
Muredach P. Reilly
Muredach P. Reilly Columbia University
Katherine M. Detre
Katherine M. Detre University of Pittsburgh
Unnur Thorsteinsdottir
Unnur Thorsteinsdottir deCODE Genetics (Iceland)
Kari Stefansson
Kari Stefansson deCODE Genetics (Iceland)
David P. Faxon
David P. Faxon Brigham and Women's Hospital
Howard C. Herrmann
Howard C. Herrmann University of Pennsylvania

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring related healthcare careers can offer flexibility and open doors beyond traditional medicine. Medical billing and coding schools with financial aid provide convenient pathways into vital administrative roles that support the healthcare industry. These programs often offer flexible schedules and financial support, making them accessible for a range of students.

For aspiring nurses, there are LPN to RN programs without TEAS test requirements. These innovative options help current practical nurses advance their careers more quickly and reduce barriers to vital nursing credentials.

If you're interested in healthcare leadership, consider an accelerated healthcare administration degree. These online programs allow students to enter management positions in hospitals, clinics, and other healthcare settings faster than ever before.

Lastly, registered nurses looking to specialize can explore ADN to FNP programs. These bridge programs enable nurses to advance to the role of Family Nurse Practitioner, expanding their clinical expertise and career opportunities.

Best Scientists Citing Robert L. Wilensky

Trending Scientists

Recently Published Articles